← Eichor
Condition: Prostate Biopsy Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Prostate Biopsy

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

An Investigational Scan (18F-rhPSMA-7.3 PET-mpMRI) for Targeted Prostate Biopsy Using TRUS-MR Fusion Technique
Phase 2 · 1 location(s) · Emory University · NCT06865768The Added-value of PSMA PET in Detecting Clinically Significant Prostate Cancer Lesions in Patients Undergoing MRI-targe
NA · 1 location(s) · Jules Bordet Institute · NCT06867588POSLUMA® (18F-rhPSMA-7.3) PET-CT for PIRADS 2/3 Lesions
Phase 2 · 1 location(s) · University of Florida · NCT07220720Personalized Optimization of Systematic Prostate Biopsy
NA · 1 location(s) · Fujian Medical University Union Hospital · NCT05998278Cognitive and Fusion Prostatic Biopsy
NA · 2 location(s) · Menoufia University · NCT07306741Diagnostic Utility of rhPSMA-7.3 (18F) PET/CT in Men With Prostate Cancer on Active Surveillance
Phase 2 · 1 location(s) · Icahn School of Medicine at Mount Sinai · NCT07285057Evaluation of Perilesional Biopsy in Diagnosis of Prostate Cancer
NA · 1 location(s) · Peking University First Hospital · NCT06482645Early Detection of Prostate Cancer
NA · 4 location(s) · University Hospital, Montpellier · NCT04556916INSIGHT-PCa: MRI- and PHI-Guided Risk-Adapted Strategy for Prostate Cancer Diagnosis
NA · 1 location(s) · In Gab Jeong, MD · NCT07398690Diagnostic Value of MRI-targeted Plus Index-lesion-ipsilaterally Systematic Biopsy for Biopsy-naive Men At Risk of Prost
Phase N/A · 1 location(s) · The Affiliated Nanjing Drum Tower Hospital of Nanjing Univer · NCT06584279Investigation of Impact of AI on Prostate Cancer Workflow
NA · 1 location(s) · Case Comprehensive Cancer Center · NCT07084779Comparison of New SUREcore Biopsy of Needle to Standard of Care During Transperineal Prostate Biopsies
NA · 1 location(s) · University of California, Davis · NCT06907446Pathological Positivity Rate in Prostate Cancer Patients with PI-RADS 4 and First Negative Biopsy
Phase N/A · 1 location(s) · Anhui Provincial Hospital · NCT06677775Liquid Biopsy Under PSMA Radioligand Therapy
Phase N/A · 3 location(s) · Wuerzburg University Hospital · NCT07118436Plasma Exosomal RNA Signature for Prostate Cancer Bone Metastasis
Phase N/A · 9 location(s) · Xijing Hospital · NCT07553754Imperial Prostate 7 - Prostate Assessment Using Comparative Interventions - Fast Mri and Image-fusion for Cancer
NA · 15 location(s) · Imperial College London · NCT05574647The CCANED-CIPHER Study: Early Cancer Detection and Treatment Response Monitoring Using AI-Based Platelet and Immune Cel
Phase N/A · 4 location(s) · Javier Toledo · NCT06717295GUidance In Prostate Cancer DEtection With 18F-PSMA-1007-PET/MRI and Targeted Biopsies
NA · 2 location(s) · Mads Ryo Jochumsen · NCT07258056Image-Guided Biopsies to Identify Mechanisms of Resistance in Patients With Metastatic Castration Resistant Prostate Can
Phase 1 · 1 location(s) · Jonsson Comprehensive Cancer Center · NCT05398302Fusion or Cognitive Ultrasound-guided Biopsy to Detect Prostate Cancer
NA · 4 location(s) · Albany Medical College · NCT06517901Feasibility and Impact of Liquid Biopsy Genomic Profiling on Treatment Patients With Metastatic Prostate Cancer in Spain
Phase N/A · 1 location(s) · SOLTI Breast Cancer Research Group · NCT05885009PRostate Cancer Plasma Integrative Multi-modal Evaluation
Phase N/A · 4 location(s) · Santa Chiara Hospital · NCT06981377Trial of Curcumin to Prevent Progression of Low-risk Prostate Cancer Under Active Surveillance
Phase 3 · 1 location(s) · University of Texas Southwestern Medical Center · NCT03769766Multiparametric Magnetic Resonance Imaging of the Prostate to Assess Disease Progression and Genomics in Patients Underg
NA · 1 location(s) · National Cancer Institute (NCI) · NCT04692675Diffusion Basis Spectrum Imaging of the Prostate
NA · 1 location(s) · Washington University School of Medicine · NCT04420702PSMA PET Combined With MRI for the Detection of PCa
Phase 3 · 18 location(s) · Telix Pharmaceuticals (Innovations) Pty Limited · NCT07052214ProBio: A Biomarker Driven Study in Patients With Metastatic Prostate Cancer
Phase 3 · 32 location(s) · Karolinska Institutet · NCT03903835Comparison of TB+PB and TB+6SB for Prostate Cancer Diagnosis
NA · 1 location(s) · Peking University First Hospital · NCT07460843Comparing MRI-Ultrasound Fusion and Cognitive-guided Biopsy for the Detection of csPCa: the PROFUSION Trial
NA · 1 location(s) · Chinese University of Hong Kong · NCT06303622Combining High-frequency Micro-ultrasound and Multiparametric MRI Target Biopsy for Detecting Prostate Cancer
NA · 1 location(s) · Salzburger Landeskliniken · NCT06579911
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.